Bridge Biotherapeutics, Inc. 288330.KQ Stock
Bridge Biotherapeutics, Inc. Price Chart
Bridge Biotherapeutics, Inc. 288330.KQ Financial and Trading Overview
| Bridge Biotherapeutics, Inc. stock price | 5850 KRW |
| Previous Close | 7450 KRW |
| Open | 7500 KRW |
| Bid | 7440 KRW x N/A |
| Ask | 8000 KRW x N/A |
| Day's Range | 7350 - 7590 KRW |
| 52 Week Range | 7150 - 13300 KRW |
| Volume | 33.37K KRW |
| Avg. Volume | 61.12K KRW |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.983686 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
288330.KQ Valuation Measures
| Enterprise Value | 111.94B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 78.726 |
| Enterprise Value/EBITDA | -2.667 |
Trading Information
Bridge Biotherapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 0.983686 |
| 52-Week Change | -23.35% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13300 KRW |
| 52 Week Low | 7150 KRW |
| 50-Day Moving Average | 8563.4 KRW |
| 200-Day Moving Average | 9871.65 KRW |
288330.KQ Share Statistics
| Avg. Volume (3 month) | 61.12K KRW |
| Avg. Daily Volume (10-Days) | 32.11K KRW |
| Shares Outstanding | N/A |
| Float | 10.63M |
| Short Ratio | N/A |
| % Held by Insiders | 28.08% |
| % Held by Institutions | 15.44% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2980.21% |
| Gross Margin | 17.10% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.048% |
| Return on Equity (ttm) | -75.40% |
Income Statement
| Revenue (ttm) | 1.42B KRW |
| Revenue Per Share (ttm) | 71.87 KRW |
| Quarterly Revenue Growth (yoy) | -35.39% |
| Gross Profit (ttm) | -1124214190 KRW |
| EBITDA | -41981206528 KRW |
| Net Income Avi to Common (ttm) | -42300764160 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 60.64B KRW |
| Total Cash Per Share (mrq) | 3047.68 KRW |
| Total Debt (mrq) | 97.23M KRW |
| Total Debt/Equity (mrq) | 0.15 KRW |
| Current Ratio (mrq) | 24.98 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -38658846720 KRW |
| Levered Free Cash Flow (ttm) | -23237206016 KRW |
Profile of Bridge Biotherapeutics, Inc.
| Country | South Korea |
| State | N/A |
| City | Seongnam |
| Address | Building B, Innovalley |
| ZIP | 13486 |
| Phone | N/A |
| Website | https://bridgebiorx.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 36 |
Bridge Biotherapeutics, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide. Its products in pipeline includes BBT-401, a Pellino-1 inhibitor, which is in Phase I clinical trial for the treatment of ulcerative colitis; and BBT-877, an autotaxin inhibitor that is in Phase I clinical trial for the treatment of various fibrotic diseases, such as idiopathic pulmonary fibrosis. Bridge Biotherapeutics, Inc. has a research collaboration with Atomwise to launch small molecule programs across various therapeutic areas using structure-based AI technology for drug discovery. The company was founded in 2015 and is headquartered in Seongnam, Korea.
Q&A For Bridge Biotherapeutics, Inc. Stock
What is a current 288330.KQ stock price?
Bridge Biotherapeutics, Inc. 288330.KQ stock price today per share is 5850 KRW.
How to purchase Bridge Biotherapeutics, Inc. stock?
You can buy 288330.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bridge Biotherapeutics, Inc.?
The stock symbol or ticker of Bridge Biotherapeutics, Inc. is 288330.KQ.
How many shares does Bridge Biotherapeutics, Inc. have in circulation?
The max supply of Bridge Biotherapeutics, Inc. shares is 21.31M.
What is Bridge Biotherapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Bridge Biotherapeutics, Inc. PE Ratio is now.
What was Bridge Biotherapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Bridge Biotherapeutics, Inc. EPS is 0 KRW over the trailing 12 months.
Bridge Biotherapeutics, Inc. 288330.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Composite Index KQ11 | 848.53 KRW 0.64 USD |
-1.39
|
546.42K KRW 412 USD | 842.84 KRW 0.64 USD | 851.22 KRW 0.64 USD | — - | 546.42K KRW 412 USD |
| Kosdaq Manufacturing Index KQ12 | 2779.56 KRW 2.1 USD |
-1.27
|
210.65K KRW 159 USD | 2753.96 KRW 2.08 USD | 2788.98 KRW 2.11 USD | — - | 210.65K KRW 159 USD |
| Kosdaq MID300 Index KQ300 | 720.6 KRW 0.54 USD |
-1.89
|
70.17K KRW 53 USD | 716.77 KRW 0.54 USD | 724.74 KRW 0.55 USD | — - | 70.17K KRW 53 USD |
| Kosdaq Pharmaceuticals Index KQ26 | 9230.64 KRW 6.97 USD |
-0.48
|
22.23K KRW 17 USD | 9102.9 KRW 6.87 USD | 9268.21 KRW 7 USD | — - | 22.23K KRW 17 USD |
- {{ link.label }} {{link}}